亚洲和美洲寨卡病毒与登革病毒感染后抗体交叉中和的纵向分析
研究在拉丁美洲和亚洲实验室确诊登革病毒感染者感染后3年内的纵向血清标本中检测寨卡病毒和登革病毒1-4型中和抗体,并评估寨卡患者感染后6个月内的中和抗体。寨卡患者对寨卡病毒中和抗体滴度最高,对登革病毒1-4型交叉反应低;原发和继发登革感染中对寨卡病毒中和抗体滴度明显低于对感染登革病毒和异源登革血清型。交叉中和在恢复早期最强,随后寨卡中和下降并维持在低水平。
要点
- 寨卡患者对寨卡病毒中和抗体滴度最高,对登革病毒1-4型交叉反应低。
- 原发和继发登革感染中对寨卡病毒中和抗体滴度明显低于对感染登革病毒和异源登革血清型。
- 交叉中和在恢复早期最强,随后寨卡中和下降并保持在低水平。
核心结论
- 抗体交叉中和模式提示寨卡病毒位于登革病毒血清复合物之外。
- 当所有病毒同时分析时,中和抗体滴度可区分寨卡病毒与登革病毒感染。
- 这些发现对理解自然免疫和疫苗有启示。
研究设计与样本
- 研究在拉丁美洲和亚洲实验室确诊登革病毒感染者感染后3年内的纵向血清标本中检测寨卡病毒和登革病毒1-4型中和抗体。
- 研究还评估寨卡患者感染后6个月内的寨卡病毒和登革病毒1-4型中和抗体。
主要发现
- 寨卡患者对寨卡病毒中和抗体滴度最高,对登革病毒1-4型交叉反应低,且在登革免疫个体中更高。
- 原发和继发登革感染中对寨卡病毒中和抗体滴度明显低于对感染登革病毒和异源登革血清型。
- 交叉中和在恢复早期最强,随后寨卡中和下降并随时间维持在低水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The 4 dengue virus serotypes (DENV1-4) and Zika virus (ZIKV) are related mosquito-borne flaviviruses of major importance globally. While monoclonal antibodies and plasma from DENV-immune donors can neutralize or enhance ZIKV in vitro and in small-animal models, and vice versa, the extent, duration, and significance of cross-reactivity in humans remains unknown, particularly in flavivirus-endemic regions. METHODS: We studied neutralizing antibodies to ZIKV and DENV1-4 in longitudinal serologic specimens collected through 3 years after infection from people in Latin America and Asia with laboratory-confirmed DENV infections. We also evaluated neutralizing antibodies to ZIKV and DENV1-4 in patients with Zika through 6 months after infection. RESULTS: In patients with Zika, the highest neutralizing antibody titers were to ZIKV, with low-level cross-reactivity to DENV1-4 that was greater in DENV-immune individuals. We found that, in primary and secondary DENV infections, neutralizing antibody titers to ZIKV were markedly lower than to the infecting DENV and heterologous DENV serotypes. Cross-neutralization was greatest in early convalescence, then ZIKV neutralization decreased, remaining at low levels over time. CONCLUSIONS: Patterns of antibody cross-neutralization suggest that ZIKV lies outside the DENV serocomplex. Neutralizing antibody titers can distinguish ZIKV from DENV infections when all viruses are analyzed simultaneously. These findings have implications for understanding natural immunity and vaccines.
引用
- Montoya M, Collins M, Dejnirattisai W, et al. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas. J Infect Dis. 2018. PMID: 29618091. doi:10.1093/infdis/jiy164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。